KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Goodwill (2016 - 2023)

Inovio Pharmaceuticals' Goodwill history spans 11 years, with the latest figure at $10.5 million for Q1 2023.

  • For Q1 2023, Goodwill changed N/A year-over-year to $10.5 million; the TTM value through Mar 2023 reached $10.5 million, changed N/A, while the annual FY2020 figure was $10.5 million, N/A changed from the prior year.
  • Goodwill for Q1 2023 was $10.5 million at Inovio Pharmaceuticals, roughly flat from $10.5 million in the prior quarter.
  • Across five years, Goodwill topped out at $10.5 million in Q4 2020 and bottomed at $10.5 million in Q4 2020.
  • The 3-year median for Goodwill is $10.5 million (2020), against an average of $10.5 million.